Page last updated: 2024-11-03

propofol and MPTP Neurotoxicity Syndrome

propofol has been researched along with MPTP Neurotoxicity Syndrome in 1 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"Propofol is an intravenous anesthetic widely used for sedation and general anesthesia."1.37Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease. ( Inada, T; Kubo, K; Shingu, K, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kubo, K1
Inada, T1
Shingu, K1

Other Studies

1 other study available for propofol and MPTP Neurotoxicity Syndrome

ArticleYear
Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
    Brain research, 2011, Apr-28, Volume: 1387

    Topics: Animals; Blotting, Western; Cell Separation; Cyclooxygenase 1; Cyclooxygenase 2; Disease Models, Ani

2011